Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Effect of long-term pharmacological treatments on Alzheimer disease: A systematic review and network meta-analysis

Deng X, Li D.

Medicine (Baltimore). 2024 Sep 20;103(38):e39753. doi: 10.1097/MD.0000000000039753.

Understanding genetics, sex and signaling: Implications of sex-dependent APOE4-neutrophil-microglia interactions for Alzheimer's and tauopathies

Haag N, Bremer J, Zempel H.

Signal Transduct Target Ther. 2024 Sep 23;9(1):252. doi: 10.1038/s41392-024-01967-1.

Post-Hoc Assessment of Cognitive Efficacy in Alzheimer's Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial

Ayasse ND, Stewart WF, Lipton RB, Gomez-Ulloa D, Runken MC.

Curr Alzheimer Res. 2024;21(5):353-365. doi: 10.2174/0115672050316936240905064215.

Progress of researches on the mechanism of acupuncture treatment for Alzheimer's disease by modulating synaptic plasticity

Ren DL, Wei YT, Su ML, Zhu TT, Yan XK.

Zhen Ci Yan Jiu. 2024 Aug 25;49(8):858-866. doi: 10.13702/j.1000-0607.20230279.

Microglia and gut microbiota: A double-edged sword in Alzheimer's disease

Bano N, Khan S, Ahamad S, Kanshana JS, Dar NJ, Khan S, Nazir A, Bhat SA.

Ageing Res Rev. 2024 Nov;101:102515. doi: 10.1016/j.arr.2024.102515. Epub 2024 Sep 24.

Phyto-nanotechnology: A novel beneficial strategy for Alzheimer's disease therapy

Ganguly SC, Sangram S, Paul S, Kundu M.

Neurochem Int. 2024 Nov;180:105868. doi: 10.1016/j.neuint.2024.105868. Epub 2024 Sep 25.

Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer's disease research

Granzotto A, Vissel B, Sensi SL.

Elife. 2024 Sep 27;13:e90633. doi: 10.7554/eLife.90633.

Non-Pharmacological Exercise Randomized Controlled Trials in Alzheimer's Disease

Wang N, Tai HC, Tzeng IS.

J Alzheimers Dis. 2024;101(s1):S537-S544. doi: 10.3233/JAD-240418.

The role and mechanism of dapagliflozin in Alzheimer disease: A review

Chen P, Liang L, Dai Y, Hui S.

Medicine (Baltimore). 2024 Sep 27;103(39):e39687. doi: 10.1097/MD.0000000000039687.

What's in It for Me? Contextualizing the Potential Clinical Impacts of Lecanemab, Donanemab, and Other Anti-β-amyloid Monoclonal Antibodies in Early Alzheimer's Disease

Jin M, Noble JM.

eNeuro. 2024 Sep 27;11(9):ENEURO.0088-24.2024. doi: 10.1523/ENEURO.0088-24.2024. Print 2024 Sep.

NMDARs in Alzheimer's Disease: Between Synaptic and Extrasynaptic Membranes

Escamilla S, Sáez-Valero J, Cuchillo-Ibáñez I.

Int J Mol Sci. 2024 Sep 23;25(18):10220. doi: 10.3390/ijms251810220.

p38α Mitogen-Activated Protein Kinase-An Emerging Drug Target for the Treatment of Alzheimer's Disease

Detka J, Płachtij N, Strzelec M, Manik A, Sałat K.

Molecules. 2024 Sep 13;29(18):4354. doi: 10.3390/molecules29184354.

[Type 2 diabetes and Alzheimer's disease - are there common microbial roots?]

Fekete C, Schandl L, Tomasics G, Egey A, Kis J, Winkler G.

Orv Hetil. 2024 Sep 29;165(39):1522-1528. doi: 10.1556/650.2024.33128. Print 2024 Sep 29.

Therapeutic approaches to microglial dysfunction in Alzheimer's disease: Enhancing phagocytosis and metabolic regulation

Almalki WH, Almujri SS.

Pathol Res Pract. 2024 Nov;263:155614. doi: 10.1016/j.prp.2024.155614. Epub 2024 Sep 25.

Mechanisms Underlying Obesity-induced Aβ Accumulation in Alzheimer's Disease: A Qualitative Review

Wen W, Huang SM, Zhang B.

J Integr Neurosci. 2024 Sep 5;23(9):163. doi: 10.31083/j.jin2309163.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias